Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AbbVie’s Battle Over Alvotech’s Biosimilar Humira Moves To New Ground With ITC Investigation
Jan 28 2022
•
By
Brenda Sandburg
ITC institutes investigation of manufacturing process for Alvotech's Humira biosimilar • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics